Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Fowler

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|February 16, 2010
Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancerKimberly E Resnick, Wendy L Frankel, Carl D Morrison, et al.
Gynecologic Oncology|November 26, 2016
Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?Blair Smith, Georgia A McCann, Gary Phillips, et al.
Gynecologic Oncology|December 8, 2004
Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patientsJames C Pavelka, Inbar Ben-Shachar, Jeffrey M Fowler, et al.
Obstetrics and Gynecology|June 24, 2009
Comprehensive surgical staging for endometrial cancer in obese patients: comparing robotics and laparotomyLeigh G Seamon, Shannon A Bryant, Patrick S Rheaume, et al.
Gynecologic Oncology|August 14, 2012
Recurrent ovarian cancer: is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen?Georgia A McCann, Blair Smith, Floor J Backes, et al.
Journal of Robotic Surgery|September 18, 2016
Robotic hysterectomy and lymphadenectomy for endometrial cancer: technical aspects and details of success-the Ohio State University methodLeigh G Seamon, David E Cohn, Sue Valmadre, et al.
Obstetrics and Gynecology|November 2, 2006
Improved survival with an intact DNA mismatch repair system in endometrial cancerDavid E Cohn, Wendy L Frankel, Kimberly E Resnick, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2009
Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancerNina A Mayr, Jian Z Wang, Simon S Lo, et al.
The Oncologist|August 17, 2021
Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?Casey M Cosgrove, Floor J Backes, David O'Malley, et al.
Gynecologic Oncology|June 10, 2014
A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancerEric L Eisenhauer, Vanna Zanagnolo, David E Cohn, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|February 16, 2010
Mismatch repair status and outcomes after adjuvant therapy in patients with surgically staged endometrial cancerKimberly E Resnick, Wendy L Frankel, Carl D Morrison, et al.
Gynecologic Oncology|November 26, 2016
Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?Blair Smith, Georgia A McCann, Gary Phillips, et al.
Gynecologic Oncology|December 8, 2004
Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patientsJames C Pavelka, Inbar Ben-Shachar, Jeffrey M Fowler, et al.
Obstetrics and Gynecology|June 24, 2009
Comprehensive surgical staging for endometrial cancer in obese patients: comparing robotics and laparotomyLeigh G Seamon, Shannon A Bryant, Patrick S Rheaume, et al.
Gynecologic Oncology|August 14, 2012
Recurrent ovarian cancer: is there a role for re-treatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen?Georgia A McCann, Blair Smith, Floor J Backes, et al.
Journal of Robotic Surgery|September 18, 2016
Robotic hysterectomy and lymphadenectomy for endometrial cancer: technical aspects and details of success-the Ohio State University methodLeigh G Seamon, David E Cohn, Sue Valmadre, et al.
Obstetrics and Gynecology|November 2, 2006
Improved survival with an intact DNA mismatch repair system in endometrial cancerDavid E Cohn, Wendy L Frankel, Kimberly E Resnick, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2009
Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancerNina A Mayr, Jian Z Wang, Simon S Lo, et al.
The Oncologist|August 17, 2021
Endometrial Cancer: Who Lives, Who Dies, Can We Improve Their Story?Casey M Cosgrove, Floor J Backes, David O'Malley, et al.
Gynecologic Oncology|June 10, 2014
A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancerEric L Eisenhauer, Vanna Zanagnolo, David E Cohn, et al.
Pageof 11